Bahl & Gaynor Inc Bio Techne Corp Transaction History

Bahl & Gaynor Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 09, 2018	SELL	$147.44 - $204.11 $1.92 Million - $2.66 Million	-13,012 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $1.85 Million - $2.12 Million	-12,783 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$131.46 - $151.04 $59,551 - $68,421	453 Added 3.67%	12,783 $1.93 Million
Q4 2017 Feb 13, 2018	BUY	$121.17 - $134.75 $82,395 - $91,630	680 Added 5.84%	12,330 $1.6 Million
Q3 2017 Nov 13, 2017	SELL	$113.59 - $123.78 $52,251 - $56,938	-460 Reduced 3.8%	11,650 $1.41 Million
Q2 2017 Aug 11, 2017	BUY	N/A	4,970 Added 69.61%	12,110 $1.42 Million
Q2 2017 Aug 10, 2017	BUY	N/A	7,140	7,140 $735,000

604

153M

171K

56.9K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.09B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

Stay updated on Bahl & Gaynor Inc with notifications on news.